Skip to main content
. 2019 Oct 15;10(24):6175–6184. doi: 10.7150/jca.35901

Figure 6.

Figure 6

Cox regression analyses of the prognostic value of immunomodulators in ER-positive, ER-negative, HER2-positive and HER2-negative patients.